Glicóxeno fosforilase (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Glicóxeno fosforilase" in Galician language version.

refsWebsite

Global rank Galician rank

19nih.gov

4^th place

6^th place

14doi.org

2^nd place

7^th place

3archive.org

6^th place

8^th place

1rcsb.org

8,838^th place

735^th place

1web.archive.org

1^st place

1jbc.org

4,455^th place

611^th place

archive.org

Johnson LN (1992). "Glycogen phosphorylase: control by phosphorylation and allosteric effectors". FASEB Journal 6 (6): 2274–82. PMID 1544539.
Meyer F, Heilmeyer LM Jr, Haschke RH, Fischer EH (1970). "Control of phosphorylase activity in a muscle glycogen particle. I. Isolation and characterization of the protein-glycogen complex". Journal of Biological Chemistry 245 (24): 6642–6648. PMID 4320610.
Moller DE (2001). "New drug targets for type 2 diabetes and the metabolic syndrome". Nature 414 (6865): 821–7. PMID 11742415. doi:10.1038/414821a.

doi.org

dx.doi.org

Livanova NB, Chebotareva NA, Eronina TB, Kurganov BI (2002). "Pyridoxal 5′_Phosphate as a Catalytic and Conformational Cofactor of Muscle Glycogen Phosphorylase b". Biochemistry (Moscow) 67 (10): 1089–1998. PMID 12460107. doi:10.1023/A:1020978825802.
Palm D, Klein HW, Schinzel R, Buehner M, Helmreich, EJM (1990). "The role of pyridoxal 5'-phosphate in glycogen phosphorylase catalysis". Biochemistry 29 (5): 1099–1107. PMID 2182117. doi:10.1021/bi00457a001.
Browner MF, Fletterick RJ (1992). "Phosphorylase: a biological transducer". Trends in Biochemical Science 17 (2): 66–71. PMID 1566331. doi:10.1016/0968-0004(92)90504-3.
Newgard CB, Hwang PK, Fletterick, RJ (1989). "The family of glycogen phosphorylases: structure and function". Critical Reviews Biochemistry and Molecular Biology 24 (1): 69–99. PMID 2667896. doi:10.3109/10409238909082552.
Somsák L, Nagya V, Hadady Z, Docsa T, Gergely P. (2003). "Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments". Current Pharmacological Design 9 (15): 1177–89. PMID 12769745. doi:10.2174/1381612033454919.
Moller DE (2001). "New drug targets for type 2 diabetes and the metabolic syndrome". Nature 414 (6865): 821–7. PMID 11742415. doi:10.1038/414821a.
Oikonomakos NG, Kontou M, Zographos SE, Tsitoura HS, Johnson LN, Watson KA, Mitchell EP, Fleet GW, Son JC, Bichard CJ; et al. (1994). "The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase". European Journal of Drug Metabolism and Pharmacology 19 (3): 185–92. PMID 7867660. doi:10.1007/BF03188920.
Hopfinger A J, Reaka A, Venkatarangan P, Duca J S, Wang S. (1999). "Prediction of Ligand−Receptor Binding Free Energy by 4D-QSAR Analysis: Application to a Set of Glucose Analogue Inhibitors of Glycogen Phosphorylase". Journal of Chemical Information and Computer Science 39: 1141–1150. doi:10.1021/ci9900332.
Nogales-Gadea G, Arenas J, Andreu AL (2007). "Molecular genetics of McArdle's disease". Curr Neurol Neurosci Rep 7 (1): 84–92. PMID 17217859. doi:10.1007/s11910-007-0026-2.
Grünfeld JP, Ganeval D, Chanard J, Fardeau M, Dreyfus JC (1972). "Acute renal failure in McArdle's disease. Report of two cases". New England Journal of Medicine 286 (23): 1237–41. PMID 4502558. doi:10.1056/NEJM197206082862304.
Burwinkel B, Bakker HD, Herschkovitz E, Moses SW, Shin YS, Kilimann MW (1998). "Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI". Am. J. Hum. Genet. 62 (4): 785–91. PMC 1377030. PMID 9529348. doi:10.1086/301790.
Chang S, Rosenberg MJ, Morton H, Francomano CA, Biesecker LG (1998). "Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI". Hum. Mol. Genet. 7 (5): 865–70. PMID 9536091. doi:10.1093/hmg/7.5.865.
Tang NL, Hui J, Young E, Worthington V, To KF, Cheung KL, Li CK, Fok TF (2003). "A novel mutation (G233D) in the glycogen phosphorylase gene in a patient with hepatic glycogen storage disease and residual enzyme activity". Molecular Genetics and Metabolism 79 (2): 142–145. PMID 12809646. doi:10.1016/S1096-7192(03)00068-4.
Shimada S, Matsuzaki H, Marutsuka T, Shiomori K, Ogawa M (2001). "Gastric and intestinal phenotypes of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase". J. Gastroenterol. 36 (7): 457–64. PMID 11480789. doi:10.1007/s005350170068.

jbc.org

Cori GT, Green AA (1943). "Crystalline muscle phosphorylase II prosthetic group". Journal of Biological Chemistry 151 (1): 21–29. Arquivado dende o orixinal o 27 de abril de 2017. Consultado o 29 de agosto de 2012.

nih.gov

ncbi.nlm.nih.gov

Livanova NB, Chebotareva NA, Eronina TB, Kurganov BI (2002). "Pyridoxal 5′_Phosphate as a Catalytic and Conformational Cofactor of Muscle Glycogen Phosphorylase b". Biochemistry (Moscow) 67 (10): 1089–1998. PMID 12460107. doi:10.1023/A:1020978825802.
Palm D, Klein HW, Schinzel R, Buehner M, Helmreich, EJM (1990). "The role of pyridoxal 5'-phosphate in glycogen phosphorylase catalysis". Biochemistry 29 (5): 1099–1107. PMID 2182117. doi:10.1021/bi00457a001.
Browner MF, Fletterick RJ (1992). "Phosphorylase: a biological transducer". Trends in Biochemical Science 17 (2): 66–71. PMID 1566331. doi:10.1016/0968-0004(92)90504-3.
Johnson LN (1992). "Glycogen phosphorylase: control by phosphorylation and allosteric effectors". FASEB Journal 6 (6): 2274–82. PMID 1544539.
Newgard CB, Hwang PK, Fletterick, RJ (1989). "The family of glycogen phosphorylases: structure and function". Critical Reviews Biochemistry and Molecular Biology 24 (1): 69–99. PMID 2667896. doi:10.3109/10409238909082552.
Johnson LN, Barford, D (1990). "Glycogen phosphorylase. The structural basis of the allosteric response and comparison with other allosteric proteins.". Journal of Biological Chemistry 265 (5): 2409–2412. PMID 2137445.
Meyer F, Heilmeyer LM Jr, Haschke RH, Fischer EH (1970). "Control of phosphorylase activity in a muscle glycogen particle. I. Isolation and characterization of the protein-glycogen complex". Journal of Biological Chemistry 245 (24): 6642–6648. PMID 4320610.
David ES, Crerar MM (1986). "Quantitation of muscle glycogen phosphorylase mRNA and enzyme amounts in adult rat tissues". Biochim. Biophys. Acta 880 (1): 78–90. PMID 3510670.
Somsák L, Nagya V, Hadady Z, Docsa T, Gergely P. (2003). "Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments". Current Pharmacological Design 9 (15): 1177–89. PMID 12769745. doi:10.2174/1381612033454919.
Moller DE (2001). "New drug targets for type 2 diabetes and the metabolic syndrome". Nature 414 (6865): 821–7. PMID 11742415. doi:10.1038/414821a.
Coats WS, Browner MF, Fletterick RJ, Newgard CB (1991). "An engineered liver glycogen phosphorylase with AMP allosteric activation". Journal of Biological Chemistry 266 (24): 16113–9. PMID 1874749.
Oikonomakos NG, Kontou M, Zographos SE, Tsitoura HS, Johnson LN, Watson KA, Mitchell EP, Fleet GW, Son JC, Bichard CJ; et al. (1994). "The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase". European Journal of Drug Metabolism and Pharmacology 19 (3): 185–92. PMID 7867660. doi:10.1007/BF03188920.
Nogales-Gadea G, Arenas J, Andreu AL (2007). "Molecular genetics of McArdle's disease". Curr Neurol Neurosci Rep 7 (1): 84–92. PMID 17217859. doi:10.1007/s11910-007-0026-2.
Andreu AL, Nogales-Gadea G, Cassandrini D, Arenas J, Bruno C (2007). "McArdle disease: molecular genetic update". Acta Myol 26 (1): 53–7. PMID 17915571.
Grünfeld JP, Ganeval D, Chanard J, Fardeau M, Dreyfus JC (1972). "Acute renal failure in McArdle's disease. Report of two cases". New England Journal of Medicine 286 (23): 1237–41. PMID 4502558. doi:10.1056/NEJM197206082862304.
Burwinkel B, Bakker HD, Herschkovitz E, Moses SW, Shin YS, Kilimann MW (1998). "Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI". Am. J. Hum. Genet. 62 (4): 785–91. PMC 1377030. PMID 9529348. doi:10.1086/301790.
Chang S, Rosenberg MJ, Morton H, Francomano CA, Biesecker LG (1998). "Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI". Hum. Mol. Genet. 7 (5): 865–70. PMID 9536091. doi:10.1093/hmg/7.5.865.
Tang NL, Hui J, Young E, Worthington V, To KF, Cheung KL, Li CK, Fok TF (2003). "A novel mutation (G233D) in the glycogen phosphorylase gene in a patient with hepatic glycogen storage disease and residual enzyme activity". Molecular Genetics and Metabolism 79 (2): 142–145. PMID 12809646. doi:10.1016/S1096-7192(03)00068-4.
Shimada S, Matsuzaki H, Marutsuka T, Shiomori K, Ogawa M (2001). "Gastric and intestinal phenotypes of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase". J. Gastroenterol. 36 (7): 457–64. PMID 11480789. doi:10.1007/s005350170068.

rcsb.org

PDB 3E3N

web.archive.org

Cori GT, Green AA (1943). "Crystalline muscle phosphorylase II prosthetic group". Journal of Biological Chemistry 151 (1): 21–29. Arquivado dende o orixinal o 27 de abril de 2017. Consultado o 29 de agosto de 2012.